Economic analysis of two structured treatment and teaching programs on asthma

Area of Science:

• Pulmonary Medicine
• Health Economics
• Public Health

Background:

• Asthma management requires effective educational and treatment programs.
• Evaluating the economic impact of healthcare interventions is crucial for policy decisions.

Purpose of the Study:

• To assess medical outcomes of two asthma programs: complete (CP) and reduced (RP).
• To conduct cost-analysis, cost-benefit analysis, and cost-effectiveness analysis from multiple perspectives.
• To determine the economic value of asthma management programs.

Main Methods:

• Randomized controlled trial comparing CP (asthma school) and RP (booklet education).
• Outcome variables included asthma attacks, urgent medical visits, hospital admissions, and lost workdays.
• Economic analyses were performed from the perspective of Health Program Policymakers (HPP) and Society as a Whole (SaW).

Main Results:

• No significant differences in medical outcomes (asthma attacks, urgent visits, admissions, lost workdays) between CP and RP.
• Both programs demonstrated positive morbidity savings and net cost-benefits.
• The complete program (CP) yielded slightly higher cost-benefit ratios and was marginally more cost-effective than the reduced program (RP).

Conclusions:

• Both asthma management programs are economically viable, offering significant returns on investment.
• The complete program (CP) appears slightly more beneficial for patient welfare and cost-effectiveness.
• Sensitivity analysis suggested potential advantages for the reduced program (RP) under certain conditions, warranting further investigation.